Tìm kiếm
Monopar Therapeutics Inc
MNPRThêm vào danh sách theo dõi
88.840USD
-0.540-0.60%
Đóng cửa 09-24 16:00（ET）
595.23MVốn hóa
LỗP/E TTM
Sau giờ giao dịch 16:41 (ET)88.800USD-0.300-0.34%
Sau giờ giao dịch 16:41 (ET)Giới thiệu về Monopar Therapeutics Inc Công ty
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.
Monopar Therapeutics Inc Hồ sơ
Mã chứng khoánMNPR
Tên công tyMonopar Therapeutics Inc
Ngày IPODec 19, 2019
Giám đốc điều hànhRobinson (Chandler D)
Số lượng nhân viên16
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhDec 19
Địa chỉ1000 Skokie Blvd Ste 350
Thành phốWILMETTE
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện60091-1146
Điện thoại18473880349
Trang webhttps://www.monopartx.com/
Mã chứng khoánMNPR
Ngày IPODec 19, 2019
Giám đốc điều hànhRobinson (Chandler D)
Lãnh đạo công ty của Monopar Therapeutics Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Chandler D. Robinson, M.D.
Dr. Chandler D. Robinson, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
162.08K
+5.42%
Dr. Chandler D. Robinson, M.D.
Dr. Chandler D. Robinson, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
162.08K
+5.42%
Dr. Chandler D. Robinson, M.D.
Dr. Chandler D. Robinson, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
162.08K
+5.42%
Dr. Christopher M. (Chris) Starr, Ph.D.
Dr. Christopher M. (Chris) Starr, Ph.D.
Executive Chairman of the Board, Independent Director
Executive Chairman of the Board, Independent Director
15.05K
-6.64%
Dr. Christopher M. (Chris) Starr, Ph.D.
Dr. Christopher M. (Chris) Starr, Ph.D.
Executive Chairman of the Board, Independent Director
Executive Chairman of the Board, Independent Director
15.05K
-6.64%
Dr. Christopher M. (Chris) Starr, Ph.D.
Dr. Christopher M. (Chris) Starr, Ph.D.
Executive Chairman of the Board, Independent Director
Executive Chairman of the Board, Independent Director
15.05K
-6.64%
Ms. Lavina Talukdar
Ms. Lavina Talukdar
Independent Director
Independent Director
14.00K
--
Ms. Lavina Talukdar
Ms. Lavina Talukdar
Independent Director
Independent Director
14.00K
--
Ms. Lavina Talukdar
Ms. Lavina Talukdar
Independent Director
Independent Director
14.00K
--
Ms. Kim R. Tsuchimoto
Ms. Kim R. Tsuchimoto
Director
Director
11.49K
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Chandler D. Robinson, M.D.
Dr. Chandler D. Robinson, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
162.08K
+5.42%
Dr. Chandler D. Robinson, M.D.
Dr. Chandler D. Robinson, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
162.08K
+5.42%
Dr. Chandler D. Robinson, M.D.
Dr. Chandler D. Robinson, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
162.08K
+5.42%
Dr. Christopher M. (Chris) Starr, Ph.D.
Dr. Christopher M. (Chris) Starr, Ph.D.
Executive Chairman of the Board, Independent Director
Executive Chairman of the Board, Independent Director
15.05K
-6.64%
Dr. Christopher M. (Chris) Starr, Ph.D.
Dr. Christopher M. (Chris) Starr, Ph.D.
Executive Chairman of the Board, Independent Director
Executive Chairman of the Board, Independent Director
15.05K
-6.64%
Dr. Christopher M. (Chris) Starr, Ph.D.
Dr. Christopher M. (Chris) Starr, Ph.D.
Executive Chairman of the Board, Independent Director
Executive Chairman of the Board, Independent Director
15.05K
-6.64%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Monopar Therapeutics Inc?
Năm cổ đông hàng đầu của Monopar Therapeutics Inc là: Dr. Chandler D. Robinson, M.D.
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Monopar Therapeutics Inc (MNPR)?
Tính đến ngày 2026Q1, có 147 tổ chức nắm giữ cổ phiếu của Monopar Therapeutics Inc, với tổng giá trị thị trường khoảng 5.90M, chiếm 88.03% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm 1082274.00.